A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study

BACKGROUND: Despite its common use in cancer treatment, radiotherapy has not yet entered the era of precision medicine, and there have been no approaches to adjust dose based on biological differences between or within tumours. We aimed to assess whether a patient-specific molecular signature of rad...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Lancet Oncol
Autores principales: Scott, Jacob G, Berglund, Anders, Schell, Michael J, Mihaylov, Ivaylo, Fulp, William J, Yue, Binglin, Welsh, Eric, Caudell, Jimmy J, Ahmed, Kamran, Strom, Tobin S, Mellon, Eric, Venkat, Puja, Johnstone, Peter, Foekens, John, Lee, Jae, Moros, Eduardo, Dalton, William S, Eschrich, Steven A, McLeod, Howard, Harrison, Louis B, Torres-Roca, Javier F
Formato: Artigo
Lenguaje:Inglês
Publicado: 2016
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7771305/
https://ncbi.nlm.nih.gov/pubmed/27993569
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1470-2045(16)30648-9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares